The perceived lack of drug discovery productivity in recent times
has led to much debate in the pharmaceutical/biotechnology industry
as escalating R&D costs are not being matched by increased
output. Few observers doubt that selecting the right targets, ie
those which are critical to disease pathology and are druggable, is
the best starting point for improved productivity.
The seven chapters of this volume describe recent progress towards
drugs acting at a range of druggable targets. One chapter addresses
kinases, one covers an ion channel, two proteases are featured and
three of the chapters cover G-protein coupled receptors, which has
historically perhaps been the most fruitful area for medicinal
chemists.
*Presents the latest research in the field of drug discovery
*Publishes on an annual basis to bring you the most innovative
updates in medicinal chemistry
*Available as an online resource via ScienceDirect
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
